Recent Updates
Recently added Catalysts
CTMX Positive Sentiment

CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Thursday, December 21, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CytomX Therapeutics, a leader in localized biologics, has announced that its CEO, Sean McCarthy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. The event highlights the company's commitment to engaging with investors and showcasing its innovations in the biotech field. A live webcast of the presentation will be available on the company's website, along with a replay for those unable to attend. Additionally, management will hold one-on-one meetings with registered investors at the conference.
Price reaction · baseline $1.34 (2023-12-20 close) · hit after-hours · clean, no other CTMX news in the window
day 0 close
+5.2%
day 1
+7.5%
day 3 · peak
+15.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is participating in a prestigious conference.
  • The CEO's presentation could raise investor interest and awareness.
  • Investors have the opportunity for one-on-one meetings with management.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
6.8%
average across 7 past catalysts
Cash runway
~54 mo
Minimal dilution risk
Lead asset
CX-2009
Phase 2 · Neoplasms

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 5:15 p.m. PT.
A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. An archived replay will be available for 30 days following the event. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conference.
About CytomX Therapeutics
SVP, Finance and Accounting
Investor and Media Contact:

Frequently Asked Questions

When is CytomX Therapeutics presenting at the JPMorgan Conference?

CytomX will present on January 10, 2024, at 5:15 p.m. PT.

Who will represent CytomX at the conference?

Sean McCarthy, D.Phil., will represent CytomX at the conference.

Where can I watch the live presentation?

The live webcast will be available on CytomX’s Events and Presentations page.

How long will the presentation replay be available?

The archived replay will be accessible for 30 days after the event.

Can investors meet with CytomX management during the conference?

Yes, registered investors can have one-on-one meetings with management.

ShareAdd on Google
Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics J.P. Morgan Conference biologics healthcare
Last updated: Dec 21, 2023

Biotech snapshot

Cash runway
$330M liquidity · $6M/mo burn
~54 mo
Minimal dilution risk
Lead asset
CX-2009Phase 2
Neoplasms →

Catalyst track record

+53%
best trade around CTMX's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for CTMX.

See every catalyst's timing & PoA →